Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (NXSCF)
OTHER OTC:NXSCF
NXSCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.17
Previous CloseN/A
Volume6.25K
Average Volume (3M)4.37K
Market Cap
$27.70M
Enterprise Value$26.18M
Total Cash (Recent Filing)$1.67M
Total Debt (Recent Filing)$2.49M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding292,625,370
10 Day Avg. Volume2,696
30 Day Avg. Volume4,368
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit1.42
Enterprise Value/Ebitda-6.35
Forecast
1Y Price Target
$0.26Price Target Upside333.33% Upside
Rating ConsensusHold
Number of Analyst Covering0
Next Science Ltd News
NXSCF FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest stock price was $0.02 and its highest was $0.17 in the past 12 months.
What is Next Science Ltd’s market cap?
Next Science Ltd’s market cap is $27.70M.
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 179 days.
How were Next Science Ltd’s earnings last quarter?
Next Science Ltd released its earnings results on Aug 28, 2025. The company reported -$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.016.
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Undervalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 292,625,370 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Next Science Ltd reported an EPS of -$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in NXSCF
Next Science Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.26 (333.33% Upside)
$0.26 (333.33% Upside)
Blogger Sentiment
Bullish
NXSCF Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-62.73%
12-Months-Change
Fundamentals
Return on Equity
-289.70%
Trailing 12-Months
Asset Growth
-19.99%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.
Technical Analysis
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Cronos Australia Ltd.
―
Ownership Overview
0.39% Insiders
<0.01% Other Institutional Investors
99.61% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---